Analysts were largely expecting an 8-10 per cent rise in net profit for the quarter.

Here are a few stocks which may buzz the most in today's trade.

Natco Pharma Ltd on Wednesday launched brand Bortenat, used in the treatment of plasma cell cancer, in injection form.